A patient presents with mild jaundice, splenomegaly, and ultrasonography findings of gallstones. Peripheral smear examination reveals generalized red cell targeting and occasional cells with angular crystals of hemoglobin C. The formation of hemoglobin C involves the substitution of glutamic acid with which of the following amino acids?
Which of the following represents fetal hemoglobin (HbF)?
Which among the following describes the quaternary structure of hemoglobin?
True regarding the conversion of deoxyhemoglobin to oxyhemoglobin is
Haptoglobin levels are decreased in which of the following conditions?
What is true regarding HbA2?
In sickle cell trait, how many bands are typically found?
Which of the following pigments is NOT derived from hemoglobin?
Hemoglobin catabolism leads to the formation of which intermediate product before bilirubin is formed?
Which of the following amino acids is essential for the synthesis of heme?
Explanation: ### Explanation **Correct Option: C. Lysine** The clinical presentation of mild jaundice, splenomegaly, and pigment gallstones suggests a chronic hemolytic process. The presence of **target cells** and **rhomboid/angular hemoglobin crystals** on a peripheral smear is pathognomonic for **Hemoglobin C (HbC) disease**. HbC is caused by a point mutation in the **6th position of the β-globin chain**, where the negatively charged **Glutamic acid** is replaced by the positively charged **Lysine**. This substitution reduces the solubility of the hemoglobin molecule, leading to the formation of intracellular crystals and decreased red cell lifespan. **Analysis of Incorrect Options:** * **A. Valine:** This is the substitution seen in **Sickle Cell Anemia (HbS)**. At the 6th position of the β-chain, Glutamic acid is replaced by Valine (a non-polar amino acid), leading to polymerization under deoxygenated conditions. * **B. Leucine:** This amino acid is not typically associated with the common hemoglobinopathies (HbS or HbC) tested in NEET-PG. * **D. Arginine:** While Arginine is a basic amino acid like Lysine, it is not the specific residue involved in the HbC mutation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for 6th position mutations:** "6th position **S**ubstitution: **V**al-**S**ickle, **L**ys-**C**" (S-V-L-C). * **Electrophoresis:** On alkaline electrophoresis, HbC moves the slowest (closest to the cathode) because Lysine is highly positive. The order of mobility from cathode to anode is **C → S → F → A** (Mnemonic: **C**rawl, **S**low, **F**ast, **A**ccelerate). * **Target Cells:** Commonly seen in HbC, Thalassemia, Liver disease, and Post-splenectomy (Mnemonic: **HALT**). * **HbSC Disease:** Patients with both mutations (HbS and HbC) often present with more severe clinical features than HbC alone, including vaso-occlusive crises.
Explanation: ### Explanation **Correct Answer: B. Alpha2Gamma2 ($\alpha_2\gamma_2$)** Hemoglobin is a tetrameric protein composed of two pairs of globin chains. The specific combination of these chains determines the type of hemoglobin: 1. **Fetal Hemoglobin (HbF):** Composed of **two alpha ($\alpha$) and two gamma ($\gamma$) chains**. HbF is the predominant hemoglobin during fetal life (from 3 months gestation until birth). Its physiological significance lies in its **higher affinity for oxygen** compared to adult hemoglobin (HbA). This is because $\gamma$-chains do not bind 2,3-Bisphosphoglycerate (2,3-BPG) effectively, allowing the fetus to extract oxygen from maternal blood across the placenta. --- ### Analysis of Incorrect Options: * **A. Alpha2Beta2 ($\alpha_2\beta_2$):** This represents **HbA (Adult Hemoglobin)**, which constitutes about 97% of hemoglobin in a normal adult. * **C. Alpha2Delta2 ($\alpha_2\delta_2$):** This represents **HbA2**, a minor adult hemoglobin that normally accounts for about 2–3% of total hemoglobin. * **D. Delta4 ($\delta_4$):** This is not a physiological hemoglobin. However, **Gamma4 ($\gamma_4$)** is known as **Hb Barts** (seen in Alpha-thalassemia/Hydrops fetalis), and **Beta4 ($\beta_4$)** is known as **HbH**. --- ### High-Yield NEET-PG Pearls: * **Switching:** HbF levels start to decline at birth and are replaced by HbA. By 6 months of age, HbF usually drops to <1%. * **HbF in Disease:** HbF levels are elevated in $\beta$-thalassemia major and Sickle Cell Anemia as a compensatory mechanism. * **Induction:** **Hydroxyurea** is used in Sickle Cell Anemia because it increases the production of HbF, which inhibits the polymerization of HbS. * **Chromosomes:** Alpha chains are coded on **Chromosome 16**, while Beta, Gamma, and Delta chains are coded on **Chromosome 11**.
Explanation: **Explanation:** Hemoglobin (HbA) is a globular protein responsible for oxygen transport. Its **quaternary structure** is defined as a **tetramer**, specifically a "dimer of dimers." It consists of four polypeptide subunits: two alpha ($\alpha$) chains and two beta ($\beta$) chains ($ \alpha_2\beta_2$). These four subunits are held together by non-covalent interactions (hydrophobic, ionic, and hydrogen bonds), allowing for **cooperative binding** of oxygen. **Analysis of Options:** * **Tetramer (Correct):** Hemoglobin consists of four subunits, each containing a prosthetic heme group. This structure is essential for the **Bohr effect** and the sigmoidal oxygen dissociation curve. * **Monomer (Incorrect):** **Myoglobin** is a monomer (single polypeptide chain). Unlike hemoglobin, it lacks a quaternary structure and shows a hyperbolic dissociation curve. * **Homodimer (Incorrect):** This would imply two identical subunits. While Hb has two pairs of identical chains, the functional molecule requires all four. * **Heterodimer (Incorrect):** While hemoglobin is often described as a dimer of $\alpha\beta$ heterodimers ($[\alpha\beta]_1 + [\alpha\beta]_2$), the complete, functional physiological unit is the tetramer. **High-Yield Clinical Pearls for NEET-PG:** 1. **T and R States:** The tetramer exists in two states: the **T (Tense)** state (low oxygen affinity, deoxyhemoglobin) and the **R (Relaxed)** state (high oxygen affinity, oxyhemoglobin). 2. **2,3-BPG:** This molecule binds to the central cavity of the deoxyhemoglobin tetramer, stabilizing the T-state and shifting the curve to the right. 3. **Fetal Hemoglobin (HbF):** A tetramer composed of $\alpha_2\gamma_2$. It has a higher affinity for $O_2$ because it binds 2,3-BPG less strongly. 4. **Sickle Cell Anemia:** A point mutation in the $\beta$-chain causes the hemoglobin tetramers to polymerize under deoxygenated conditions.
Explanation: ### Explanation The conversion of deoxyhemoglobin (T-state) to oxyhemoglobin (R-state) is governed by the **Bohr Effect** and the reciprocal relationship between oxygen and its allosteric effectors. **1. Why Option A is Correct:** The **Bohr Effect** states that hemoglobin’s oxygen affinity is inversely related to acidity and $CO_2$ concentration. When oxygen binds to deoxyhemoglobin, it triggers a conformational change from the T (Tense) state to the R (Relaxed) state. This transition ruptures salt bridges, leading to the **release of protons ($H^+$)**. Mathematically, this is represented as: $HHb + O_2 \rightleftharpoons HbO_2 + H^+$ Thus, oxygenation promotes the dissociation of protons. **2. Why the Other Options are Incorrect:** * **Option B:** One mole of deoxyhemoglobin binds exactly **one mole** of 2,3-DPG. The 2,3-DPG molecule sits in the central cavity between the two beta-chains, stabilized by positive charges. * **Option C:** The pH has a significant effect. A **decrease in pH** (acidosis) shifts the oxygen dissociation curve (ODC) to the **right**, decreasing oxygen affinity (facilitating unloading), while an increase in pH shifts it to the left. * **Option D:** Binding of $O_2$ causes the **expulsion** of 2,3-DPG. 2,3-DPG stabilizes the T-state (deoxy); therefore, for oxygen to bind and transition the hemoglobin to the R-state, 2,3-DPG must be released. **Clinical Pearls for NEET-PG:** * **Haldane Effect:** Describes how oxygenation of hemoglobin in the lungs promotes the displacement of $CO_2$ (The opposite of the Bohr effect). * **2,3-DPG:** Levels increase in chronic hypoxia, high altitudes, and anemia to facilitate oxygen delivery to tissues. * **Fetal Hemoglobin (HbF):** Has a lower affinity for 2,3-DPG due to the substitution of Serine for Histidine in the $\gamma$-chains, resulting in a higher oxygen affinity than HbA.
Explanation: **Explanation:** The primary function of **Haptoglobin** is to bind free hemoglobin (Hb) released into the plasma during **intravascular hemolysis**. Once the Haptoglobin-Hemoglobin complex is formed, it is rapidly cleared by the reticuloendothelial system (specifically by CD163 receptors on macrophages) to prevent iron loss and oxidative kidney damage. Consequently, serum haptoglobin levels drop significantly—often to undetectable levels—whenever significant hemolysis occurs. **Analysis of Options:** * **Mismatched Transfusion Reactions:** This is a classic example of acute intravascular hemolysis. Antibodies (isohemagglutinins) attack donor RBCs, causing immediate lysis and a massive release of free Hb, which consumes haptoglobin. * **Thalassemia:** While primarily characterized by ineffective erythropoiesis, there is a significant component of both extravascular and intravascular hemolysis due to the precipitation of unpaired globin chains, leading to reduced haptoglobin levels. * **G6PD Deficiency:** During an oxidative crisis (triggered by fava beans or drugs like Primaquine), RBCs undergo acute hemolysis. The resulting free hemoglobin binds to haptoglobin, leading to its depletion. Since all three conditions involve the destruction of red blood cells and the release of free hemoglobin, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Sensitive Marker:** A decreased haptoglobin level is one of the most sensitive laboratory markers for identifying **hemolytic anemia**. * **Acute Phase Reactant:** Haptoglobin is a positive acute-phase reactant. Its levels may rise during inflammation, which can sometimes mask an underlying hemolytic state (false normal). * **Hemopexin:** When haptoglobin is saturated, **Hemopexin** acts as the secondary backup to bind free Heme. * **Differentiation:** Haptoglobin levels are typically **normal in iron deficiency anemia** but decreased in any condition involving shortened RBC survival.
Explanation: ### Explanation **Correct Answer: C. Its level is increased in Thalassemia.** *(Note: There appears to be a discrepancy in the provided key; in clinical biochemistry, HbA2 levels are significantly **lower** than HbA in normal adults, but their **elevation** is a diagnostic hallmark of Beta-Thalassemia trait.)* #### 1. Why Option C is the most clinically relevant "True" statement: In a normal adult, Hemoglobin A (α2β2) constitutes >95% of total hemoglobin, while **HbA2 (α2δ2)** constitutes only **1.5–3.5%**. The most important clinical fact regarding HbA2 is that its levels **increase (typically >3.5%) in Beta-Thalassemia minor**. This occurs as a compensatory mechanism because beta-chain synthesis is decreased, leading to a relative increase in delta-chain production. #### 2. Why the other options are incorrect: * **Option A:** HbA2 does not have a significantly higher oxygen-carrying capacity than HbA. While it has a slightly higher oxygen affinity (shifting the curve to the left), its primary role is not superior oxygen transport. * **Option B:** This is **incorrect**. HbA (α2β2) is the major adult hemoglobin (>95%). HbA2 is a minor component (<3.5%). * **Option D:** HbA2 consists of **2 alpha (α) and 2 delta (δ) chains**. The structure 2 alpha and 2 beta defines HbA. #### 3. High-Yield Clinical Pearls for NEET-PG: * **Normal Hemoglobin Composition (Adult):** HbA (α2β2) ~97%, HbA2 (α2δ2) ~2.5%, HbF (α2γ2) <1%. * **Beta-Thalassemia Trait:** Characterized by isolated elevation of **HbA2 (>3.5%)**. * **Iron Deficiency Anemia (IDA):** HbA2 levels are typically **decreased**. This is a crucial point for differentiating IDA from Thalassemia trait. * **Megaloblastic Anemia:** HbA2 levels can be falsely elevated. * **HbF (Fetal Hemoglobin):** Has the highest oxygen affinity to facilitate oxygen transfer from maternal to fetal blood.
Explanation: ### Explanation **1. Why Option A (2) is Correct:** Sickle cell trait (HbAS) is the heterozygous state where an individual inherits one normal $\beta$-globin gene and one mutated $\beta^S$ gene. On **Hemoglobin Electrophoresis** (alkaline pH), two distinct bands are visible: * **HbA:** Represents the normal adult hemoglobin (usually 50–60%). * **HbS:** Represents the sickle hemoglobin (usually 35–45%). Because both genes are expressed (codominance), both proteins are synthesized and separated based on their electrical charge. HbA moves faster toward the anode, while HbS moves slower due to the substitution of negatively charged glutamic acid with neutral valine at the 6th position of the $\beta$-chain. **2. Why Other Options are Incorrect:** * **Option B (1):** A single band is seen in normal adults (HbA) or those with homozygous Sickle Cell Disease (HbSS), where only HbS (and some HbF) is present. * **Option C & D (4 or 5):** These are incorrect as they do not correspond to the standard electrophoretic pattern of sickle cell trait. Multiple bands (3 or more) might be seen in complex compound heterozygous states (e.g., HbSC or HbS-$\beta$ Thalassemia) where HbF and HbA2 are also significantly elevated. **3. Clinical Pearls for NEET-PG:** * **Electrophoresis Mobility (Alkaline pH):** Remember the mnemonic **"A Fat Santa Claus"** (from fastest to slowest: Hb**A** > Hb**F** > Hb**S** > Hb**C**). * **HbS Mutation:** Point mutation (GAG $\rightarrow$ GTG) resulting in **Valine** replacing **Glutamic acid** at the 6th position of the $\beta$-globin chain. * **Sickle Cell Trait Protection:** Individuals with HbAS are naturally protected against severe *Plasmodium falciparum* malaria. * **Diagnosis:** In Sickle Cell Trait, HbA is always greater than HbS (HbA > HbS). If HbS > HbA, suspect $S\beta^+$ thalassemia.
Explanation: ### Explanation The correct answer is **C. Lipofuscin**. **1. Why Lipofuscin is the correct answer:** Lipofuscin is known as the "wear-and-tear" or "aging" pigment. Unlike the other options, it is **not** derived from the breakdown of hemoglobin or iron. Instead, it is a product of **lipid peroxidation** of polyunsaturated fatty acids of subcellular membranes. It represents indigestible material within lysosomes and is typically found in aging cells, particularly in the heart (brown atrophy), liver, and neurons. **2. Why the other options are incorrect:** * **Hematin (Option A):** This is an oxidation product of hemoglobin where the iron atom is converted from the ferrous ($Fe^{2+}$) to the ferric ($Fe^{3+}$) state. It is seen in conditions like malaria (hemozoin). * **Hemosiderin (Option B):** This is an iron-storage complex. When there is an excess of iron (derived from the heme portion of hemoglobin), it is stored as ferritin or aggregates into golden-yellow granules called hemosiderin. * **Bilirubin (Option D):** This is the primary catabolic product of the heme moiety of hemoglobin. After the removal of iron, the protoporphyrin ring is converted into biliverdin and then into bilirubin. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Prussian Blue Stain:** Stains **Hemosiderin** blue (Perls' reaction). It does **not** stain Lipofuscin or Bilirubin. * **Lipofuscin Appearance:** Appears as yellow-brown, finely granular cytoplasmic pigment. It is a marker of past free radical injury. * **Bilirubin Staining:** Best visualized using the **Fouchet stain**. * **Hematoidin:** A hemoglobin-derived pigment chemically similar to bilirubin but formed in tissues (e.g., old infarcts/bruises) in an anaerobic environment; it is iron-free.
Explanation: **Explanation:** The catabolism of hemoglobin occurs primarily in the reticuloendothelial system (spleen and liver). The process begins when senescent red blood cells are lysed, releasing hemoglobin. 1. **Why Biliverdin is correct:** The first step in heme degradation is catalyzed by the enzyme **Heme Oxygenase**. This enzyme breaks the porphyrin ring, releasing iron ($Fe^{2+}$) and carbon monoxide (CO), resulting in the formation of **Biliverdin**, a green pigment. Biliverdin is then subsequently reduced to Bilirubin (yellow pigment) by the enzyme *Biliverdin Reductase*. Therefore, Biliverdin is the immediate intermediate product. 2. **Why other options are incorrect:** * **Bilirubin diglucuronide:** This is the "conjugated" form of bilirubin produced in the liver by the enzyme *UDP-glucuronyltransferase*. It occurs *after* bilirubin formation to make it water-soluble for excretion. * **Urobilin:** This is an oxidation product of urobilinogen found in urine, giving it its characteristic yellow color. It is a late-stage metabolite formed by intestinal bacteria. * **Stercobilin:** This is the oxidized form of stercobilinogen excreted in feces, providing the brown color. Like urobilin, it is formed much later in the pathway within the intestine. **High-Yield Clinical Pearls for NEET-PG:** * **Heme Oxygenase** is the only endogenous source of **Carbon Monoxide (CO)** in the human body. * **Rate-limiting step:** The conversion of heme to biliverdin by Heme Oxygenase. * **Van den Bergh Reaction:** Used to differentiate between conjugated (direct) and unconjugated (indirect) bilirubin. * **Crigler-Najjar & Gilbert Syndromes:** Result from deficiencies in the conjugation enzyme *UDP-glucuronyltransferase*.
Explanation: **Explanation:** **1. Why Glycine is Correct:** The synthesis of heme begins in the mitochondria with the condensation of **Succinyl CoA** and the amino acid **Glycine**. This reaction is catalyzed by the enzyme **ALA Synthase (ALAS)**, which requires Pyridoxal Phosphate (Vitamin B6) as a cofactor. This is the **rate-limiting step** of heme biosynthesis. Glycine provides the nitrogen and carbon atoms necessary to form the pyrrole ring, which eventually constitutes the tetrapyrrole structure of heme. **2. Why Other Options are Incorrect:** * **Lysine:** An essential basic amino acid primarily involved in protein synthesis and collagen cross-linking; it does not participate in the heme pathway. * **Arginine:** A precursor for Nitric Oxide (NO), urea, and creatine. While vital for the urea cycle, it has no role in porphyrin synthesis. * **Glutamine:** Acts as a major nitrogen donor for purine and pyrimidine synthesis (nucleotide metabolism) but is not a substrate for heme. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Enzyme:** ALA Synthase (ALAS1 in liver, ALAS2 in erythroid cells). * **Cofactor Alert:** Deficiency of **Vitamin B6** can lead to Sideroblastic Anemia because ALA synthase cannot function without it. * **Inhibitors:** Lead poisoning inhibits **ALA Dehydratase** and **Ferrochelatase**, leading to increased ALA levels and stippled RBCs. * **Heme vs. Globin:** While Glycine is needed for the *heme* part, the *globin* part is a protein synthesized on ribosomes like any other protein. * **Mnemonic:** "Sucking Glycine" (Succinyl CoA + Glycine) to remember the starting substrates.
Hemoglobin Structure and Function
Practice Questions
Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve
Practice Questions
Hemoglobin Variants and Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Methemoglobin and Abnormal Hemoglobins
Practice Questions
Hemoglobin Synthesis
Practice Questions
Heme Synthesis and Porphyrias
Practice Questions
Iron Absorption and Transport
Practice Questions
Iron Storage and Recycling
Practice Questions
Disorders of Iron Metabolism
Practice Questions
Anemia: Biochemical Aspects
Practice Questions
Biochemistry of Hemostasis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free